Bowhead Specialty (NYSE:BOW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Bowhead Specialty (NYSE:BOW) had its price objective upped by analysts at JPMorgan Chase & Co. from $30.00 to $33.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 8.62% from the stock’s previous close.

BOW has been the topic of several other research reports. Citizens Jmp decreased their price objective on Bowhead Specialty from $38.00 to $35.00 and set a “market outperform” rating on the stock in a research note on Monday, April 13th. Keefe, Bruyette & Woods boosted their price objective on Bowhead Specialty from $34.00 to $36.00 and gave the company an “outperform” rating in a research note on Wednesday, July 8th. UBS Group set a $28.00 target price on shares of Bowhead Specialty in a report on Thursday, May 21st. Weiss Ratings upgraded shares of Bowhead Specialty from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 23rd. Finally, Royal Bank Of Canada lifted their price target on shares of Bowhead Specialty from $30.00 to $38.00 and gave the company an “outperform” rating in a report on Monday, July 13th. Five research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $33.71.

Bowhead Specialty Price Performance

Shares of Bowhead Specialty stock opened at $30.38 on Monday. Bowhead Specialty has a one year low of $21.21 and a one year high of $33.86. The stock’s fifty day moving average is $28.59 and its 200 day moving average is $25.82. The stock has a market cap of $997.62 million, a P/E ratio of 17.56, a P/E/G ratio of 0.92 and a beta of -0.10. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.47 and a current ratio of 0.47.

Bowhead Specialty (NYSE:BOW) last released its earnings results on Tuesday, May 5th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.06. Bowhead Specialty had a return on equity of 13.80% and a net margin of 9.99%.The company had revenue of $155.69 million for the quarter, compared to the consensus estimate of $211.74 million. Sell-side analysts anticipate that Bowhead Specialty will post 1.97 earnings per share for the current year.

Hedge Funds Weigh In On Bowhead Specialty

Large investors have recently made changes to their positions in the business. Langdon Equity Partners bought a new position in shares of Bowhead Specialty in the fourth quarter worth about $28,000. Versant Capital Management Inc grew its position in shares of Bowhead Specialty by 262.6% during the second quarter. Versant Capital Management Inc now owns 1,037 shares of the company’s stock worth $31,000 after purchasing an additional 751 shares in the last quarter. Raymond James Financial Inc. bought a new stake in Bowhead Specialty during the 2nd quarter valued at approximately $52,000. CWM LLC raised its stake in Bowhead Specialty by 257.7% during the 4th quarter. CWM LLC now owns 1,481 shares of the company’s stock valued at $42,000 after purchasing an additional 1,067 shares during the period. Finally, Parallel Advisors LLC lifted its holdings in Bowhead Specialty by 181.4% in the 1st quarter. Parallel Advisors LLC now owns 1,652 shares of the company’s stock worth $37,000 after purchasing an additional 1,065 shares in the last quarter.

About Bowhead Specialty

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.